This new resource provides clear, accessible information on key topics for anyone seeking to better understand VWD, including symptoms, diagnosis, testing methods, treatment options, menstrual health and more.

Pfizer has announced the death of a participant enrolled in the long-term open-label extension study (B7841007) of marstacimab in individuals with haemophilia A or B, with or without inhibitors.

Throughout 2025, we have strengthened our foundations as a credible and mature organisation, reinforced our collective voice, and further clarified our role in supporting National Member Organisations (NMOs) across Europe.

On World Mental Health Day, the EHC releases the Executive Summary of its Round Table on Addressing Mental Health in the Bleeding Disorders Community, emphasising the urgent need to support the psychological well-being of those affected by bleeding disorders.

The EHC marks World Geriatric Day 2025 with the launch of “Living Well, Ageing Well”, a new comprehensive one-year project addressing all aspects of ageing with a bleeding disorder. This timely initiative brings together leading experts, patients, and caregivers.

On 23 September 2025, the EHC hosted the round table on “Beyond the Diagnosis: Addressing Mental Health in the Bleeding Disorders Community” at the Warwick Hotel in Brussels, Belgium, bringing together healthcare professionals, policy makers, and community advocates.